Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ORNL Launches Rapid Access Licensing Program to Speed Up COVID-19 Solutions - Ink World Magazine

What are you searching for?

Sign in
Flexible Electronics News

ORNL Launches Rapid Access Licensing Program to Speed Up COVID-19 Solutions

The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.

Author Image

By: Anthony Locicero

Copy editor, New York Post

The Department of Energy’s Oak Ridge National Laboratory has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. 

 

The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.

 

“As ORNL races to find solutions to the COVID-19 pandemic, the Technology Transfer Office is working to provide streamlined processes and easy access to intellectual property so that companies can work with ORNL to quickly address this public health crisis,” said Jennifer Caldwell, ORNL’s group leader for technology commercialization.

 

In collaboration with researchers, ORNL’s Technology Transfer Office is creating a growing portfolio of inventions available to license through the program. 

 

The licenses are nonexclusive, meaning more than one person can hold the right to use the technology. Interested licensees must demonstrate intent to use ORNL’s innovations to address COVID-19 and commit to disseminating resulting products as widely and quickly as possible. 

 

Only U.S. entities, companies and universities are eligible.

 

Alternative licenses will be available for companies creating products that require exclusivity to support large development investments, such as for diagnostic platforms, drug delivery systems, therapies and vaccines.

 

ORNL has quickly responded to the COVID-19 pandemic through its research efforts in computational science, advanced manufacturing, data science and neutron science. 

 

Inventions available to license through this program represent ORNL strengths in these areas as well as in areas ranging from biological sciences to spectrometry to next-generation materials.

 

“ORNL has shown leadership in adapting our research, operations and community engagement efforts to combat COVID-19 and mitigate its effects on our community,” ORNL Director Thomas Zacharia said. “We are pleased to now offer industry partners a quicker and easier way to use our strong technology portfolio for COVID-19 solutions.”

Add us as a preferred source on Google

Get the latest Ink World magazine news, insights and analysis in your Google Search and AI experiences.

Add Ink World magazine as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters